Pharmatop Co.,ltd. is a Company Limited, established on 21 Apr 2010 and registered in Bangkok, Thailand. The Company’s principal business is manufacture of pharmaceuticals, medicinal chemical products. Pharmatop Co.,ltd. has been operating for 16 years and its current status is Active.
Profile
Company DetailsCompany record
- Legal name
- Pharmatop Co.,ltd.
- Registration number
- 0105553051982
- Entity type
- Company Limited
- Status
- Active
- Registered date
- 21 Apr 2010
- Registered capital (THB)
- THB 10,000,000
- Industry group
- Manufacturing
- TSIC activity
- Manufacture of pharmaceuticals, medicinal chemical products
Contact DetailsRegistered contact information
- Registered address
- 21/2, Soi Woraphong, Sam Sen, Ban Phan Thom, Phra Nakhon, Bangkok 10200
- Operational address
- Locked🔒
- Website
- Locked🔒
- Telephone
- Locked🔒
People
ManagementRecorded directors and signatory
- Weera PhiravaranuphongDirector
ShareholderShareholding of Pharmatop Co.,ltd.
Ownership records and shareholder relationships require premium access.
- ✓Shareholder names and holdings
- ✓Ownership percentages and changes
Financial
Credit RatingCredit rating for Pharmatop Co.,ltd.
Credit assessment and supporting financial indicators require premium access.
- ✓Credit rating and payment profile
- ✓Financial strength and risk indicators
Risk
Government ConnectionGovernment connection checks for Pharmatop Co.,ltd.
Government ownership, control, and politically exposed person links require premium access.
- ✓Government ownership and control checks
- ✓Politically exposed person links
LitigationLitigation checks for Pharmatop Co.,ltd.
Court records and material dispute intelligence require premium access.
- ✓Civil and commercial court records
- ✓Case status and material outcomes
RegulatoryRegulatory checks for Pharmatop Co.,ltd.
Regulatory actions, sanctions, and compliance findings require premium access.
- ✓Regulatory actions and sanctions
- ✓Licence and compliance findings
Adverse MediaAdverse media checks for Pharmatop Co.,ltd.
Source-screened media coverage and reputational risk signals require premium access.
- ✓Source-screened media coverage
- ✓Material allegations and reputational signals